Issuance of 3rd tranche of €500,000 of notes convertibles into new shares
26 janv. 2022 11h45 HE
|
Deinove
Issuance of 3rd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its cash position to finance its working capital needs and the pursuance of the Phase II clinical trial...
Émission d’une 3ème tranche d’OC de 500.000€
26 janv. 2022 11h45 HE
|
Deinove
Émission d’une 3ème tranche d’OC de 500.000€ DEINOVE renforce sa trésorerie pour financer son besoin en fonds de roulement et la poursuite de l’essai clinique de Phase II évaluant DNV3837 dans les...
Issuance of 2nd tranche of €500,000 of notes convertibles into new shares
15 déc. 2021 11h45 HE
|
Deinove
Issuance of 2nd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its cash position to finance its working capital needs and the pursuance of the Phase II clinical trial...
Émission d’une 2ème tranche d’OC de 500.000€
15 déc. 2021 11h45 HE
|
Deinove
Émission d’une 2ème tranche d’OC de 500.000€ DEINOVE renforce sa trésorerie pour financer son besoin en fonds de roulement et la poursuite de l’essai clinique de Phase II évaluant DNV3837 dans les...
Issuance of a 5th tranche of 3 millions EUR of notes convertible into new shares
20 janv. 2021 12h45 HE
|
Deinove
ISSUANCE OF A 5th TRANCHE OF 3 MILLIONS EUR OF NOTES CONVERTIBLE INTO NEW SHARES DEINOVE strengthens its cash position to finance the ongoing clinical trial testing DNV3837 for the treatment of...
Emission d’une 5ème tranche d'OCA de 3 m€
20 janv. 2021 12h45 HE
|
Deinove
EMISSION D’UNE 5ème TRANCHE D'OCA DE 3 M€ DEINOVE renforce sa trésorerie pour financer la poursuite de l’essai clinique de DNV3837 dans le traitement des infections gastro-intestinales sévères...
ICPT FINAL DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT
01 janv. 2021 19h15 HE
|
The Rosen Law Firm PA
NEW YORK, Jan. 01, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
ROSEN, A GLOBAL AND LEADING LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action – ICPT
10 déc. 2020 17h28 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ICPT
03 déc. 2020 19h45 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...